Clinical Trials Browser

Phase 2 × Unknown × olverembatinib × Clear all

NCT03883087 2023-04-03

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT03883100 2023-04-03

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Accelerated Phase